XML 27 R18.htm IDEA: XBRL DOCUMENT
v3.23.2

Workforce Reduction | 6 Months Ended
--- | ---
Jun. 30, 2023
Workforce Reduction |
Workforce Reduction | 11. Workforce Reduction In August 2022, the Company initiated a workforce reduction plan to strategically realign its operations and implement cost reduction programs to prioritize near term revenue generators and to manage and preserve cash. In connection with the reduction, the Company eliminated 14 positions, implemented tighter expense controls, and ceased non-core activities. Further, on December 16, 2022, Oncocyte initiated an additional reduction in work force involving over 40% of its full-time employees. The transition began on December 16, 2022 and was completed in February 2023. As of December 31, 2022, the Company incurred an aggregate of $1.9 million related to employee severance and benefits costs in connection with its reductions in force during fiscal year 2022. On April 12, 2023, Oncocyte announced a reduction in force involving approximately 20% of its workforce (the “April 2023 Reduction”), which management believes will extend Oncocyte’s cash runway into 2024. In connection with the April 2023 Reduction, we incurred approximately $0.3 million related to employee severance and benefits costs during the second quarter of 2023.

X
- References No definition available. + Details
Name: | OCX_DisclosureWorkforceReductionAbstract
Namespace Prefix: | OCX_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Workforce reduction [Text Block] + References No definition available. + Details
Name: | OCX_WorkforceReductionTextBlock
Namespace Prefix: | OCX_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration